Tenet Healthcare (NYSE:THC) Price Target Raised to $265.00

Tenet Healthcare (NYSE:THC) had its target price upped by Jefferies Financial Group from $250.00 to $265.00 in a research note issued to investors on Thursday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock.

Several other equities analysts have also weighed in on the stock. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Truist Financial restated a “buy” rating and set a $240.00 target price (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. Mizuho upped their price target on Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a report on Friday, October 17th. Raymond James Financial set a $245.00 target price on Tenet Healthcare in a report on Wednesday, October 29th. Finally, UBS Group upped their target price on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $242.82.

Tenet Healthcare Price Performance

NYSE THC opened at $230.90 on Thursday. The firm has a market capitalization of $20.29 billion, a PE ratio of 14.91, a P/E/G ratio of 0.96 and a beta of 1.44. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.64. Tenet Healthcare has a 12 month low of $109.82 and a 12 month high of $235.77. The company’s 50 day simple moving average is $198.82 and its 200 day simple moving average is $194.95.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period last year, the firm earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts forecast that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Nadja West sold 2,178 shares of the stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently made changes to their positions in the stock. AlphaQuest LLC raised its holdings in shares of Tenet Healthcare by 230.8% in the 2nd quarter. AlphaQuest LLC now owns 1,763 shares of the company’s stock worth $310,000 after buying an additional 1,230 shares in the last quarter. WCM Investment Management LLC lifted its holdings in shares of Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after acquiring an additional 362,083 shares during the period. Winnow Wealth LLC acquired a new stake in shares of Tenet Healthcare in the 3rd quarter valued at $1,129,000. Cerity Partners LLC increased its position in shares of Tenet Healthcare by 10.4% during the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after purchasing an additional 11,395 shares in the last quarter. Finally, Savant Capital LLC lifted its holdings in Tenet Healthcare by 27.5% during the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after purchasing an additional 3,647 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.